Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W E Wade

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
American Journal of Orthopedics (Belle Mead, N.J.)|April 29, 1999
Cost effectiveness of danaparoid compared with enoxaparin as deep vein thrombosis prophylaxis after hip replacement surgeryW E Wade
Clinical Therapeutics|May 20, 1998
Cost analysis of ardeparin versus enoxaparin for the prophylaxis of deep vein thrombosis after knee arthroplastyW E Wade
American Journal of Physical Medicine & Rehabilitation|July 11, 1998
Cost-effectiveness of venous thrombosis prophylaxis after ischemic strokeW E Wade
Thrombosis Research|July 3, 1998
Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: an assessment of currently available literatureW E Wade
Kansas Medicine : the Journal of the Kansas Medical Society|March 1, 1986
Challenge and responsibilityW E Wade
American Family Physician|May 1, 1993
Aminoglycosides for infections in the elderlyW E Wade
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 26, 2000
Deep venous thrombosis prophylaxis in trauma: cost analysisW E Wade, M A Chisholm
Hospital Formulary|February 1, 1995
How a CQI program improved aminoglycoside use in a community hospitalW E Wade, C Y McCall
American Journal of Physical Medicine & Rehabilitation|November 18, 2000
Venous thrombosis after acute spinal cord injury: cost analysis of prophylaxis guidelinesW E Wade, M A Chisholm
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 3, 1999
Factors influencing students' attitudes toward pharmaceutical careM A Chisholm, W E Wade
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
American Journal of Orthopedics (Belle Mead, N.J.)|April 29, 1999
Cost effectiveness of danaparoid compared with enoxaparin as deep vein thrombosis prophylaxis after hip replacement surgeryW E Wade
Clinical Therapeutics|May 20, 1998
Cost analysis of ardeparin versus enoxaparin for the prophylaxis of deep vein thrombosis after knee arthroplastyW E Wade
American Journal of Physical Medicine & Rehabilitation|July 11, 1998
Cost-effectiveness of venous thrombosis prophylaxis after ischemic strokeW E Wade
Thrombosis Research|July 3, 1998
Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: an assessment of currently available literatureW E Wade
Kansas Medicine : the Journal of the Kansas Medical Society|March 1, 1986
Challenge and responsibilityW E Wade
American Family Physician|May 1, 1993
Aminoglycosides for infections in the elderlyW E Wade
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 26, 2000
Deep venous thrombosis prophylaxis in trauma: cost analysisW E Wade, M A Chisholm
Hospital Formulary|February 1, 1995
How a CQI program improved aminoglycoside use in a community hospitalW E Wade, C Y McCall
American Journal of Physical Medicine & Rehabilitation|November 18, 2000
Venous thrombosis after acute spinal cord injury: cost analysis of prophylaxis guidelinesW E Wade, M A Chisholm
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 3, 1999
Factors influencing students' attitudes toward pharmaceutical careM A Chisholm, W E Wade
Pageof 4